Home › Chronic Myeloid Leukemia
Chronic Myeloid Leukemia clinical trials recruiting in the U.S.
48 studies for Chronic Myeloid Leukemia are recruiting participants at sites across the United States.
Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.
Cities with the most studies
- Houston, TX18 studies
- Seattle, WA11 studies
- New York City, NY11 studies
- Detroit, MI6 studies
- Birmingham, AL6 studies
- Chicago, IL6 studies
- Portland, OR6 studies
- Philadelphia, PA6 studies
- Baldwin Park, CA6 studies
- Nashville, TN5 studies
- Columbus, OH5 studies
- Baltimore, MD5 studies
- Atlanta, GA5 studies
- Durham, NC5 studies
- Boston, MA5 studies
- Milwaukee, WI5 studies
- Rochester, NY4 studies
- Cincinnati, OH4 studies
- Washington, DC4 studies
- St. Louis, MO4 studies
- Kansas City, MO4 studies
- Augusta, GA4 studies
- Mountain View, CA4 studies
- Salt Lake City, UT3 studies
- Orange, CA3 studies
- Buffalo, NY3 studies
- St. Petersburg, FL3 studies
- Bridgeport, CT3 studies
- Edison, NJ3 studies
- Cleveland, OH3 studies
- Ann Arbor, MI3 studies
- Sacramento, CA3 studies
- Aurora, CO3 studies
- Miami, FL3 studies
- Greenville, NC3 studies
- Minneapolis, MN3 studies
By state
- Alabama6 studies
- Arizona4 studies
- California10 studies
- Colorado4 studies
- District of Columbia3 studies
- Florida7 studies
- Georgia7 studies
- Illinois6 studies
- Indiana3 studies
- Kansas5 studies
- Kentucky3 studies
- Maryland6 studies
- Massachusetts5 studies
- Michigan7 studies
- Minnesota4 studies
- Missouri4 studies
- Nebraska3 studies
- New Jersey4 studies
- New York15 studies
- North Carolina8 studies
- Ohio9 studies
- Oregon6 studies
- Pennsylvania7 studies
- Tennessee5 studies
- Texas18 studies
- Utah3 studies
- Virginia4 studies
- Washington11 studies
- Wisconsin5 studies
Recently updated studies
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Oct 1, 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
RecruitingPhase 1/2
Ages 1 to 17 · All sexes · Updated Sep 25, 2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
RecruitingPhase 1
Ages 1 and older · All sexes · Updated Sep 18, 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated Sep 11, 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Sep 2, 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
RecruitingPhase 1
1 Day – 21 Years · All sexes · Updated Aug 26, 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Aug 17, 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RecruitingPhase 2
6 Months – 65 Years · All sexes · Updated Jul 22, 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
RecruitingPhase 2
Up to age 75 · All sexes · Updated Jul 6, 2026 · NCT05805605Asciminib Roll-over Study
RecruitingPhase 4
Ages 7 to 100 · All sexes · Updated Jul 6, 2026 · NCT04877522Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RecruitingPhase 2
Up to age 60 · All sexes · Updated Jun 25, 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT07638007From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.